Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
更正：免疫抑制剂FK506治疗会导致人源化小鼠中EBV相关淋巴增生性疾病的发生率更高。
期刊:PLoS Pathogens
影响因子:4.9
doi:10.1371/journal.ppat.1009167
Caduff, Nicole; McHugh, Donal; Murer, Anita; Rämer, Patrick; Raykova, Ana; Landtwing, Vanessa; Rieble, Lisa; Keller, Christian W; Prummer, Michael; Hoffmann, Laurent; Lam, Janice K P; Chiang, Alan K S; Raulf, Friedrich; Azzi, Tarik; Berger, Christoph; Rubic-Schneider, Tina; Traggiai, Elisabetta; Lünemann, Jan D; Kammüller, Michael; Münz, Christian
